Physician profile
Thomas Shook
NPI 1770838856
$2,425.53
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.05 · 2022: $2,141 · 2023: $189 · 2024: $76.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,901.30 | 2022 | |
| Pfizer INC. | $88.42 | 2022-2023 | |
| Axonics, INC. | $68.90 | 2023 | Axonics |
| Myovant Sciences INC. | $61.68 | 2022 | |
| Abbvie INC. | $55.99 | 2021-2022 | |
| Procept Biorobotics Corporation | $42.09 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Antares Pharma, INC. | $37.53 | 2022 | |
| Janssen Biotech, INC. | $32.21 | 2024 | Erleada |
| Dendreon Pharmaceuticals LLC | $26.51 | 2022 | |
| Blue Earth Diagnostics | $21.02 | 2024 | |
| Sumitomo Pharma America, INC. | $18.01 | 2023 | Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $16.47 | 2023 | |
| Astellas Pharma US INC | $15.42 | 2022 | |
| Teleflex LLC | $13.88 | 2022 | |
| Hollister Incorporated | $13.28 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Shook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.